(Q34302267)

1 August 2017

1 reference

title

Therapeutic choices for patients with hemophilia and high-titer inhibitors (English)

1 reference

1 August 2017

0 references

0 references

Kulkarni R

1

1 reference

1 August 2017

Aledort LM

2

1 reference

1 August 2017

Berntorp E

3

1 reference

1 August 2017

Brackman HH

4

1 reference

1 August 2017

Brown D

5

1 reference

1 August 2017

Cohen AR

6

1 reference

1 August 2017

Ewing NP

7

1 reference

1 August 2017

Gringeri A

8

1 reference

1 August 2017

Gruppo R

9

1 reference

1 August 2017

Hoots K

10

1 reference

1 August 2017

Leissenger C

11

1 reference

1 August 2017

Peerlinck K

12

1 reference

1 August 2017

Poon MC

13

1 reference

1 August 2017

Wong WY

14

1 reference

1 August 2017

publication date

1 August 2001

1 reference

American Journal of Hematology

1 August 2017

published in

1 reference

1 August 2017

volume

67

1 reference

1 August 2017

issue

4

1 reference

1 August 2017

page(s)

240-246

1 reference

Incidence of inhibitors in haemophilia A patients--a review of recent studies of recombinant and plasma-derived factor VIII concentrates

1 August 2017

cites work

1 reference

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

21 January 2018

1 reference

German recommendations for immune tolerance therapy in type A haemophiliacs with antibodies

21 January 2018

1 reference

Treatment options for bleeding episodes in patients undergoing immune tolerance therapy.

21 January 2018

1 reference

Immune tolerance induction in the treatment of paediatric haemophilia A patients with factor VIII inhibitors

21 January 2018

1 reference

Immune tolerance: a synopsis of the international experience

21 January 2018

1 reference

Analysis of the North American Immune Tolerance Registry (NAITR) 1993-1997: current practice implications. ISTH Factor VIII/IX Subcommittee Members

21 January 2018

1 reference

Management of haemophilia in patients with high-titre inhibitors: focus on the evolution of activated prothrombin complex concentrate AUTOPLEX T.

21 January 2018

1 reference

Immunoadsorption for removal of inhibitors: update on treatments in Malmö-Lund between 1980 and 1995.

21 January 2018

1 reference

Complications associated with the treatment of haemophiliacs with inhibitors

21 January 2018

1 reference

Use of prothrombin complex concentrates and activated prothrombin complex concentrates as prophylactic therapy in haemophilia patients with inhibitors

21 January 2018

1 reference

Thrombogenicity of prothrombin complex concentrates

21 January 2018

1 reference

Safety, efficacy and lessons from continuous infusion with rFVIIa. rFVIIa-CI Group

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/AJH.1123

1 reference

1 August 2017

1 reference